Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

1 Biotech Stock That Stands out From the Rest

Amgen (AMGN) has undertaken several strategic growth initiatives to capitalize on the expanding biotech industry. In addition, several FDA drug approvals and other research and development breakthroughs make it well-positioned to witness significant growth in the near term, making it an ideal candidate for investors seeking to gain exposure in…

StockNews.com

2 Oversold Stocks Investors Will Want to Buy Before They Blast Off

The stock market sell-offs triggered by macroeconomic and geopolitical issues since the beginning of the year have driven many quality stocks into the oversold territory. So, it could be wise to invest in oversold stocks Gilead Sciences (GILD) and Comcast (CMCSA), which have solid rebound potential. Let’s discuss….

StockNews.com

CBD, hemp, delta-8, medical marijuana: Here’s what you need to know about Texas’ pot laws

In 2019, Texas legalized hemp, but not marijuana. The new law led to confusion about which marijuana products are legal in Texas. Meanwhile, support for legalizing the drug remains high in polling, and other cannabis-derived products like delta-8 have emerged.

The Texas Tribune

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA tells shops to separate products containing THC

The Food and Drug Administration (FDA) is urging convenience stores and shopping malls to clearly demarcate areas selling cannabis-based food and snack products and ensure that sales are only to customers over the age of 20.

Bangkok Post

U.S. has "failed to contain" monkeypox, former FDA chief warns

"We're probably detecting just a fraction of the actual cases."

Axios

No Operation Warp Speed for antibiotics

Common urinary tract infections are leading to emergency room visits because of the failure of oral antibiotics

Salon

Recalled Florida ice cream had Listeria in 16 of 17 tested flavors, officials say

TAMPA, Fla. — Sixteen flavors of Sarasota-produced ice cream linked to a deadly Listeria outbreak contained the bacteria, Florida officials have confirmed.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Florida ice cream company Big Olaf recalls its products following a listeria outbreak

An outbreak in Big Olaf ice cream products that has sickened nearly two dozen people in 10 states forced the brand to recall all of its flavors and products, the Food and Drug Administration says.

WEKU

With Roe overruled, can red states disregard FDA rules on abortion pills?

WASHINGTON — When the Supreme Court overturned Roe vs. Wade last month, many abortion-rights advocates looked to pills sent by mail as a possible option for pregnant women who live in states where abortion is outlawed.

Los Angeles Times

With Roe overruled, can red states disregard FDA rules on abortion pills?

Los Angeles Times

US struggles to meet monkeypox vaccine demand

Washington (AFP) - The United States, which is forecasting an increase in monkeypox cases in the coming weeks, does not currently have enough vaccines to meet demand, a top health official said Friday.

AFP

Novavax (NVAX) Down As EU Adds Side Effects To COVID Jab Label

Shares of Novavax (NASDAQ: NVAX) fell 26.2% on Jul 14, after the European Medicines Agency's (TSE: EMA) Pharmacovigilance Risk Assessment Committee ("PRAC") updated the product label of Nuvaxovid, the company's COVID-19 vaccine, to include some potential side effects like severe aller

Benzinga

Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

StockNews.com

The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Lisa Jarvis: More COVID boosters are coming, but who will take them?

Once a week, typically on the day that the Centers for Disease Control updates its COVID data tracker, I send my dad a text: “Did you make an appointment to get your booster?”

Salon

No, BA.5 isn't evading PCR tests

Rumors abound that BA.5, or "stealth omicron," is going undetected on hospital lab tests

Reason

Why Do So Few American Women Use IUDs?

The FDA, and the Dalkon Shield scandal, deserve some of the blame.

Benzinga

APLIF: New Late Stage Program to Treat Cutaneous Leishmaniasis…

Bautz: By David Bautz, PhD OTC:APLIF | TSX:APLI.TO READ THE FULL APLIF RESEARCH REPORT

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

US regulators clear way for more monkeypox vaccine shipments

U.S. officials say thousands more doses of the monkeypox vaccine could soon begin shipping from Denmark

Reason

FDA Approves Novavax COVID-19 Vaccine, but Feds Undecided on Who It's for

Plus: The story of a 10-year-old rape victim who sought an abortion is confirmed, inflation hits a record 9.1 percent, and more...

Benzinga

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Conversation

An expert panel has recommended against taking vitamin E or beta carotene supplements for the prevention of cancer and cardiovascular disease – here's why

The U.S. Preventive Services Task Force issued a recommendation statement in June 2022 on the use of over-the-counter vitamin supplements. Based on its independent panel of experts’ review of existing scientific evidence, the task force recommended against using beta carotene or vitamin E supplements for the prevention of cancer and…

Benzinga

Benzinga Before The Bell: Tesla's AI Exec Quits, Hyundai Unveils Ioniq 6 EV, Taiwan Semiconductor's Massive Q2 Profit Surge And Other Top Financial Stories Thursday, July 14

CNBC United Airlines, Pilots’ Union To Improve Agreement By Renegotiating

Tribune News Service

Abortion medications set to become next legal battlefield

In the nearly three weeks since the U.S. Supreme Court overturned Roe v. Wade, abortion has become illegal in at least 10 states, with more states to follow in the weeks ahead.

WEKU

Over-the-counter birth control pills are available worldwide. The U.S. may be next

Birth control pills are available in the U.S. only with a prescription. Now a drugmaker is asking the FDA to approve a progestin-only contraceptive that would be available without one at pharmacies.

1 … 124 125 126 127

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

329 stories

Celsius

300 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.